Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by University of Pittsburgh.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01488318
First received: November 30, 2011
Last updated: December 6, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2014
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
No publications provided by University of Pittsburgh

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):